These compounds may interact with:
Platelet-derived growth factor receptor beta
Potentially involved in: cancer; carcinoma; hypereosinophilic syndrome; infantile myofibromatosis; basal ganglia calcification; mastocytosis; polycythemia vera; athetosis; basal ganglia diseases; blepharoptosis; bone cysts; calcinosis; malignant neoplasm of skin; chorea; corneal opacity; depressive disorder; dysarthria; dystonia; eosinophilia; epilepsy
Disease data sourced from Pharos.